Asset Management One
INSY

Asset Management One’s Insys Therapeutics, Inc. INSY Stock Holding History

Asset Management One’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-198,957
Closed -$3.16M – 1379
2016
Q1 		$3.16M Sell
198,957
-83,962
-30% -$1.59M 0.05% 461
2015
Q4 		$8.19M Sell
282,919
-54,676
-16% -$1.51M 0.12% 196
2015
Q3 		$9.22M Sell
337,595
-49,860
-13% -$1.84M 0.14% 176
2015
Q2 		$13.5M Sell
387,455
-44,009
-10% -$1.37M 0.19% 126
2015
Q1 		$12.3M Sell
431,464
-112,656
-21% -$2.98M 0.15% 162
2014
Q4 		$11.5M Buy
544,120
+205,488
+61% +$4.06M 0.15% 164
2014
Q3 		$6.65M Buy
+338,632
New +$5.32M 0.09% 267

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Asset Management One's INSY Position: Q2 2016 in Review

Asset Management One sold out of Insys Therapeutics, Inc. (INSY) in Q2 2016, closing a stake of 198,957 shares — an estimated $3.16M sold.

Asset Management One first reported a position in INSY in Q3 2014 and held it in 7 quarters. The position peaked at $13.5M in Q2 2015. 124 funds tracked by Wall St. Rank hold INSY as of Q2 2016.

  • Asset Management One reported no remaining Insys Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Asset Management One sold 198,957 Insys Therapeutics, Inc. shares in Q2 2016, an estimated $3.16M.
  • Asset Management One first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 7 quarters.
  • Asset Management One's Insys Therapeutics, Inc. position peaked at $13.5M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2016.

Based on Asset Management One's 13F filing for Q2 2016, filed 3 Aug 2016.